Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New vitamin D3 derivatives and their use described by Chugai

May 10, 2001

Cysteine protease inhibitors undergo research at Kissei

May 10, 2001

Patented series from BMS particularly useful for type 2 diabetes

May 10, 2001

Biopure's Hemopure blood substitute proves highly effective in pivotal trial

May 10, 2001

TLK-16998: a nonpeptide IR sensitizer effective in mouse models of type 2 diabetes

May 9, 2001

Theratechnologies and Alza to develop ThGRF in a Macroflux system

May 8, 2001

PTP inhibitors emerge from Novo Nordisk/Ontogen collaboration

May 7, 2001

Hectorol approved by Canadian health authorities

May 7, 2001

Novo Nordisk licenses GH-stimulating compounds to Rejuvenon

May 7, 2001

Antiatherogenic effects of J-861 attributed to potent antioxidant, free radical-scavenging actions

May 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...